|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Cutsem E, Lenz HJ, Köhne CH, Heinemann
V, Tejpar S, Melezínek I, Beier F, Stroh C, Rougier P, van Krieken
JH and Ciardiello F: Fluorouracil, leucovorin, and irinotecan plus
cetuximab treatment and RAS mutations in colorectal cancer. J Clin
Oncol. 33:692–700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang M, Miao F, Huang R, Liu W, Zhao Y,
Jiao T, Lu Y, Wu F, Wang X, Wang H, et al: RHBDD1 promotes
colorectal cancer metastasis through the Wnt signaling pathway and
its downstream target ZEB1. J Exp Clin Cancer Res. 37:222018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marquez J, Fernandez-Piñeiro I,
Araúzo-Bravo MJ, Poschmann G, Stühler K, Khatib AM, Sanchez A, Unda
F, Ibarretxe G, Bernales I and Badiola I: Targeting liver
sinusoidal endothelial cells with miR-20a-loaded nanoparticles
reduces murine colon cancer metastasis to the liver. Int J Cancer.
143:709–719. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sillars-Hardebol AH, Carvalho B, de Wit M,
Postma C, Delis-van Diemen PM, Mongera S, Ylstra B, van de Wiel MA,
Meijer GA and Fijneman RJ: Identification of key genes for
carcinogenic pathways associated with colorectal
adenoma-to-carcinoma progression. Tumour Biol. 31:89–96. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wahlestedt C: Targeting long non-coding
RNA to therapeutically upregulate gene expression. Nat Rev Drug
Discov. 12:433–446. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong HX, Wang R, Jin XY, Zeng J and Pan J:
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via
inhibiting hsa-mir 22-3p. J Cell Physiol. 233:4126–4136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen F, Yin S, Zhu J, Liu P, Yang C, Feng
Z and Deng Z: lncRNA DGCR5 acts as a tumor suppressor in papillary
thyroid carcinoma via sequestering miR-2861. Exp Ther Med.
17:895–900. 2019.PubMed/NCBI
|
|
13
|
Feiersinger F, Nolte E, Wach S, Rau TT,
Vassos N, Geppert C, Konrad A, Merkel S, Taubert H, Stürzl M and
Croner RS: MiRNA-21 expression decreases from primary tumors to
liver metastases in colorectal carcinoma. PLoS One.
11:e01485802016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hari D M, Leung AM, Lee JH, Sim MS, Vuong
B, Chiu CG and Bilchik AJ: AJCC Cancer Staging Manual 7th edition
criteria for colon cancer: Do the complex modifications improve
prognostic assessment? J Am Coll Surg. 217:181–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang R, Wang X, Zhang W, Zhangyuan G, Jin
K, Yu W, Xie Y, Xu X, Wang H and Sun B: Down-regulation of LncRNA
DGCR5 correlates with poor prognosis in hepatocellular carcinoma.
Cell Physiol Biochem. 40:707–715. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan X, Wang ZX and Wang R: MicroRNA-21: A
novel therapeutic target in human cancer. Cancer Biol Ther.
10:1224–1232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu L, Ye H, Huang G, Luo F, Liu Y, Liu Y,
Yang X, Shen J, Liu Q and Zhang J: Long noncoding RNA GAS5
suppresses the migration and invasion of hepatocellular carcinoma
cells via miR-21. Tumuor Biol. 37:2691–2702. 2016. View Article : Google Scholar
|
|
19
|
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY,
Gong W and Quan ZW: Long non-coding RNA CCAT1 promotes gallbladder
cancer development via negative modulation of miRNA-218-5p. Cell
Death Dis. 6:e15832015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Q, Chen F, Zhao J, Li B, Liang Y, Pan
W, Zhang S, Wang X and Zheng D: Long non-coding RNA PVT1 promotes
osteosarcoma development by acting as a molecular sponge to
regulate miR-195. Oncotarget. 7:82620–82633. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu Y, Zhang G, Zou C, Gong Z, Wang S, Liu
J, Ma G, Liu X, Zhang W and Jiang P: Long noncoding RNA DGCR5
suppresses gastric cancer progression by acting as a competing
endogenous RNA of PTEN and BTG1. J Cell Physiol. 234:11999–12010.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song L, Liu S, Zhang L, Yao H, Gao F, Xu D
and Li Q: MiR-21 modulates radiosensitivity of cervical cancer
through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop
and the Akt-mTOR signaling pathway. Tumuor Biol. 37:12161–12168.
2016. View Article : Google Scholar
|
|
23
|
Rana C, Piplani H, Vaish V, Nehru B and
Sanyal SN: Downregulation of PI3-K/Akt/PTEN pathway and activation
of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in
colon cancer. Mol Cell Biochem. 402:225–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang N, Chen J, Zhang H, Wang X, Yao H,
Peng Y and Zhang W: LncRNA OIP5-AS1 loss-induced microRNA-410
accumulation regulates cell proliferation and apoptosis by
targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple
myeloma. Cell Death Dis. 8:e29752017. View Article : Google Scholar : PubMed/NCBI
|
